Dr. Sabine Nikolaus

Country Managing Director Germany
Boehringer Ingelheim Deutschland

Dr. Sabine Nikolaus, born in Germany, has both a scientific and a business background: she holds a Ph.D degree in Pharmaceutical Chemistry (Universität Freiburg) and an MBA degree.

She started her career in the pharmaceutical industry 1991 in Human Pharmaceuticals sales and marketing positions and joined Boehringer Ingelheim Germany in 1995. Since then, Sabine held various marketing and sales leadership positions in Human Pharma in the German Business Unit and at Corporate Headquarters in Ingelheim.

In 2012 Dr. Sabine Nikolaus became Country Manager and Head of Human Pharma for Boehringer Ingelheim in Portugal. As of Mid 2014 she lead the Human Pharma business of 13 country organizations with more than 20 mid-and eastern European countries based at Boehringer Ingelheim’s Regional Center Vienna (RCV) in Austria.

In 2017 Dr. Sabine Nikolaus took over the position of Commercial Head of Human Pharma UK & Ireland followed by her position as Country Managing Director UK & Ireland.

Since January 2019 Dr. Sabine Nikolaus holds the position of Vorsitzende der Geschäftsführung Boehringer Ingelheim Deutschland GmbH.

  • - o'clock

    The Future of Health Systems – How should they be shaped to better prepare for pandemics?


    The state of health infrastructure in one country can profoundly affect health security worldwide as we have unfortunately learned through the current COVID 19 pandemic. The COVID-19 pandemic is a global challenge. No single government or institution can tackle the threat of future pandemics alone. It requires sustained political leadership, political will, global coordination, regulatory alignment, solidarity and continued financing. Prevention will be key to enable our healthcare systems to face long-term challenges – epidemic risks, ageing population, chronic diseases, antibiotic resistance – that threaten the sustainability of our healthcare systems. The panel on health policy will grapple with questions of effective pandemic and crisis prevention, preparedness and response and the lessons learned from the COVID-19 pandemic.

    Lord Karan Bilimoria, CBE DL, President, CBI

    Dr. Rainer Dulger, President, Confederation of German Employers' Associations (BDA)

    Dr. Sabine Nikolaus, Country Managing Director Germany, Boehringer Ingelheim Deutschland

    Dr. Bernd Ohnesorge, President (EMEA), Siemens Healthineers and Chairman of the BDI Committee for Health Industry

Overview: B7